U.S. Industrial REITs Stock News

Dillard's entered this quarter carrying a value label, with a trailing P/E below peers and a stock that recently traded under an internal fair value estimate. The market did not care today. The share price dropped about 9% as investors reacted to a much softer Q2 earnings print. The headline is the profit squeeze. Basic earnings per share for the quarter came in at US$6.26 on revenue of US$1.53b, well below the blowout Q1 figure. Same store sales growth of 1% kept the top line steady, but the...

Artesian Resources barely flinched on the screen today. The stock inched up just 0.2% even as fresh Q2 numbers put earnings power back in focus. Basic earnings per share came in at about US$0.64 on revenue of roughly US$30.7m, solid figures for a regulated water utility that investors often treat like a bond proxy. The real story sits beyond today’s tiny move. Over the past year Artesian Resources has reported high earnings quality and a P/E near 15.7x that sits below both the broader US...

Keurig Dr Pepper (NasdaqGS:KDP) announced a major brand refresh for 7UP, its first in more than 15 years, featuring a lime focused recipe and updated visual identity. The 7UP relaunch is supported by a new marketing campaign aimed at younger consumers with an emphasis on changing taste preferences. Keurig Dr Pepper also introduced co branded Dr Pepper Shake and Dr Pepper Cake Shake items through a new partnership with Portillo’s, available for a limited time. These product moves aim to...

Accelerant Holdings stock barely budged after earnings, closing at US$19.58, yet the headline numbers were anything but sleepy. The insurer swung from a small loss in Q1 to reported basic earnings per share of US$0.36 in Q2, on revenue of US$356.9 million. For a business still carrying a very large trailing twelve month loss and trading on a P/S ratio that screens cheap against specialty peers but richer than the broader US insurance group, the real story is whether this profit print is a one...

Daily Journal walked into this earnings print with its stock near record territory, up roughly 30% over the past three months and little sign of investor nerves, and the immediate reaction stayed calm with the share price edging about 0.5% higher to US$604.41 by Friday’s close. The headline is not the stock, though; it is the sharp earnings swing. Q3 brought a reported loss per share of US$7.90 and a net loss of US$10.89 million, set against a stock that still trades on a rich 8.5x P/S...

Fidelity National Financial (FNF) is back in focus after second quarter results topped Wall Street expectations, with commercial transaction activity, cost control and steadier purchase and refinance orders all playing key roles. See our latest analysis for Fidelity National Financial. At a share price of $49.47, Fidelity National Financial has seen a 1 day share price return of 1.02%, while the year to date share price return is down 8.86%. That sits alongside a 1 year total shareholder...

American Integrity Insurance Group stock barely moved on Friday, slipping just 0.04%, which indicates the market is still shrugging at what was actually a punchy insurance quarter. The company posted record pre tax income of US$46.4m with a combined ratio of 63.4%, a level many property insurers would envy. Net income reached US$34.1m or US$1.74 per share. For a stock trading on a single digit P/E and already up strongly over the past three months, this report raises a sharper question: Is...

The market nudged Applied Industrial Technologies higher by 1.2% to about US$361.95, which is a modest move for a company that just posted record fourth quarter sales and earnings. The real story sits in the profit engine. Quarterly basic earnings per share reached about US$3.21 on revenue of roughly US$1.35b, helping push trailing 12 month earnings to just over US$11 per share. With the stock already trading on a rich 32x P/E, today’s calm price reaction suggests investors are weighing...

Bullish dropped 11.2% today, which tells you traders saw red in this crypto infrastructure story. The earnings print tells a more complicated tale. Adjusted revenue held near US$92.6m and adjusted EBITDA touched roughly a 32% margin, yet the company still reported a quarterly net loss of US$270.2m. The sentiment reckoning here is simple: a richly valued stock with a P/S around 12.3x just reminded the market that the path from growth to durable profitability is still a work in progress. Is...

The market cheered Jefferson Capital today. The stock jumped 11.1% to US$24, even though the headline story inside the earnings is tighter profitability, not a sudden profit surge. Trailing net profit margins sit at 22.2%, below the 33% level of a year ago, and recent results still carry the weight of a US$66.2m one off loss. For you as an investor, this is a margin and balance sheet story, not just a revenue and P/E snapshot. The full earnings breakdown shows how Jefferson Capital is trading...

Bit Digital stock closed up about 5% today, a bounce that sits awkwardly against another heavy quarterly loss. Traders clearly focused on the headline growth in Q2 revenue and the strong 57.9% gross margin, while the market appeared to give less weight to the US$107.2m net loss that accompanied those numbers. Coming into this earnings report, Bit Digital had been roughly flat over the past month and down over the past quarter, with sentiment already fragile. Today’s rally appears to be driven...

McGraw Hill stock slipped 3.5% to US$13.10 after Q1 results, even though the numbers told a more constructive story than the price action suggests. Investors came in after a strong recent run, with the share price up over the past week and month, and then met a quarter that put profitability back in focus. The headline this time is not a flashy revenue surprise. It is the swing back to solid earnings, with Q1 basic earnings per share at US$0.30 and net income of US$57.9m. For an education...

MaxCyte just gave investors a sentiment check. The stock slipped about 5% to US$1.32 today even though Q2 revenue of US$7.3 million came in ahead of management’s own expectations and marked a sequential pickup from Q1. The real headline is not the loss per share. It is that MaxCyte is leaning on very high gross margins of 77% and a cash balance of about US$142 million to buy time for its cell engineering bets to pay off. Is MaxCyte’s premium 4.6x P/S ratio a sign the market expects that 21.1%...

Tapestry’s stock barely budged after earnings, ticking up about 0.5% to roughly US$129. For a company often tagged as a steady luxury compounder, that muted move sits awkwardly beside a headline year in the numbers. The story this quarter is profitability. Tapestry closed fiscal 2026 with trailing net profit margin near 19% and basic earnings per share over US$7, while trading on a P/E below many luxury peers. Investors now have to decide whether that kind of earnings power, paired with a...

In the past quarter, Luckin Coffee Inc. reported second-quarter 2026 revenue of CNY 15,885.62 million and net income of CNY 1,486.41 million, alongside completing a US$195.1 million repurchase of 6,100,000 shares announced on April 29, 2026. The combination of higher revenue and earnings, together with the completed buyback, points to improving profitability and management’s confidence in the business. We’ll now examine how Luckin’s stronger quarterly earnings and completed share repurchase...

Cellebrite DI walked into this print with a bruised stock that was down roughly 30% over the past month and quarter. The first trading day after results told a different story. Shares climbed about 3% as investors focused less on the near term miss to internal expectations and more on what the earnings actually showed. The headline is simple. Revenue in this quarter reached US$131.1m while Annual Recurring Revenue for Cellebrite’s digital intelligence platform stood at US$508m. At the same...

The market clipped Nomad Foods by 2.5% to €11.74 today, yet the earnings story looks more like a quiet reset than a fresh problem. Q2 net income of €48.5m and basic earnings per share of €0.35 landed against a backdrop of recent retail disruption in Germany and France that management now describes as largely resolved. The real fault line is sentiment around margins and balance sheet strain. Trailing net profit margin sits at 4.2% and management is openly prioritizing debt reduction over...

The market rushed to reward Assembly Biosciences today. The stock jumped about 10% to US$32.95, even though the company is still posting losses over the last twelve months. The emotional driver is clear. Investors are cheering a cleaner income profile after a run of heavy hits, with recent losses from continuing operations much smaller than some of the deep red quarters seen last year. For a development stage biotech, the headline is not profit. It is the scale and direction of those losses...

X-Energy stock dropped 7.7% today to about $20.98, even though the headline from this nuclear developer is about a very different kind of number. The company posted Q2 revenue of roughly $50.1 million, powered largely by advanced reactor work, while still reporting a sizeable net loss of $59.1 million. That mix of strong top line and heavy losses is the real story. Over the past month the stock is still up about 39%, and X-Energy now sits at a P/S multiple near 40x. The question for long term...

The market just knocked CuriosityStream down 11% in a single session, yet the company has just posted what looks like its cleanest profitability story so far. Heading into the release the stock had quietly climbed over the past month, then buyers stepped back right as CuriosityStream delivered record quarterly net income of US$8.9m on revenue of US$23.2m. The real swing factor is margins. A gross margin of 73% and adjusted earnings before interest, taxes, depreciation and amortization that...

Ategrity Specialty Insurance Company Holdings stock slipped 1.5% to US$24.70 into the close, yet the quarter told a very different story. The insurer turned in another strong underwriting performance, with a combined ratio of 85.9% and net income of US$33.5m anchoring the earnings headline. For a company often framed as a pure growth play in excess and surplus lines, this report was really about underwriting discipline and operating leverage. The rest of the numbers, including premium growth...

Journey Medical stock edged up 1.1% to US$6.72 into Friday’s close, a modest move for what felt like a much louder earnings moment. The company just posted Q2 revenue of US$18.5m with Emrosi contributing US$8.1m, and reported a sharply smaller net loss of US$0.3m. On the headline numbers this looks less like a euphoric breakout and more like a measured re-rating as traders weigh a dermatology story that is still loss making but inching closer to the profitability line. Impressed that Journey...

Star Bulk Carriers Corp. reported strong Q2 2026 results, with revenue of US$357.41 million, net income of US$144.95 million, and a quarterly cash dividend of US$0.90 per share declared on August 5, 2026 for payment on or about September 3, 2026. These results, alongside the dividend and ongoing fleet investments, underline the company’s current ability to generate cash and return it to shareholders while upgrading its vessels. Now we’ll examine how this robust quarterly profitability and...

With Fed Chair Kevin Warsh clamping down on forward guidance and stressing a hard 2% inflation target, every data release and Fed appearance now has the power to jolt both bonds and stocks. That kind of rate uncertainty often pushes investors toward shorter-duration cash options. This article walks through three stocks that are closely exposed to this new rate narrative and explains why they may matter for your portfolio decisions today. The stocks covered below are just a starting sample,...